Seegene Inc., a prominent player in molecular diagnostics, recently showcased two groundbreaking technologies, CURECA™ and STAgora™, at the ADLM 2025 event in Chicago. These innovations aim to revolutionize laboratory automation and data-driven infectious disease monitoring. CURECA™ stands out as the world’s first fully unattended PCR automation system, while STAgora™ is a real-time data analytics platform designed to enhance early detection and precision care.
During a press conference at ADLM 2025, Dr. Jong-Yoon Chun, Seegene’s Chairman and CEO, emphasized the significance of these advancements in shaping the future of diagnostics. The company’s goal is to facilitate global laboratories in automating complex testing processes and utilizing diagnostic data more efficiently to support the global fight against diseases. Most existing molecular testing systems rely heavily on manual steps and fixed workflows, hindering scalability and efficiency.
CURECA™ represents a significant leap in automation technology by automating every stage of PCR testing, including traditionally manual pre-treatment steps. This system addresses the challenges of full automation in diagnostics by operating without highly trained professionals, offering continuous 24-hour processing, and enabling uninterrupted specimen input. With the dedicated module, CURECA™ Prep, capable of processing various specimen types, the entire CURECA™ system streamlines the PCR workflow from sample loading to result analysis without manual intervention.
The introduction of STAgora™ complements CURECA™ by transforming diagnostic data into real-time clinical intelligence. This platform provides laboratories with over 40 analytical tools for functions like infection trend tracking, positivity monitoring, and multi-pathogen co-infection pattern analysis. STAgora™ allows hospitals to create statistical datasets, compare data across institutions, and detect infection patterns swiftly, enhancing decision-making capabilities. The platform ensures secure, de-identified data exchange at local, national, or global levels.
Seegene’s long-term vision of a world free from diseases is furthered by the integration of CURECA™ and STAgora™ into its core technology pillars. These pillars include Seegene’s proprietary PCR technology, automated assay development through SGDDS, a Technology-Sharing Initiative, and now, fully automated PCR testing and real-time data analytics capabilities. Industry experts have expressed keen interest in these technologies, acknowledging their potential to simplify laboratory workflows, reduce personnel burden, and improve operational efficiency.
Key Takeaways:
– Seegene’s CURECA™ and STAgora™ technologies introduced at ADLM 2025 revolutionize diagnostics by enhancing automation and data analytics.
– CURECA™ is the world’s first fully unattended PCR automation system, addressing the challenges of full automation in diagnostics.
– STAgora™ is a real-time data analytics platform offering over 40 analytical tools to help laboratories derive meaningful insights from diagnostic data.
– These innovations align with Seegene’s vision of building a disease-free world and are set to redefine diagnostic testing by enabling true automation and unlocking the value of diagnostic data.
Tags: automation
Read more on koreaherald.com